Wall St Price Targets

ATRY Price Forecast
Based on 5 analysts

+94% Upside
from €2.63 today

Atrys Health SA (ATRY)’s 12-month stock price forecast through October 2027 has a consensus target of €5.1, implying 94% upside. The forecast is based on price targets from 5 Wall Street analysts.

ATRY Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ATRY yet.

Atrys Health SA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ATRY's stock price target?
Price Target
5.1 EUR

According to Wall Street analysts, the average 1-year price target for ATRY is 5.1 EUR with a low forecast of 4.04 EUR and a high forecast of 5.78 EUR.

What is the Revenue forecast for Atrys Health SA?
Projected CAGR
13%

Over the last 9 years, the compound annual growth rate for Revenue has been 46%. The projected CAGR for the next 3 years is 13%.

What is the Gross Profit forecast for Atrys Health SA?
Projected CAGR
30%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 34%. The projected CAGR for the next 3 years is 30%.

Back to Top